Abbott’s Heart Valve Gets Mixed Review From FDA Advisers

Abbott Laboratories’ proposed clamp for leaky heart valves, a less-invasive option to open-chest surgery, may not be effective, U.S. regulatory advisers said.

To continue reading this article you must be a Bloomberg Professional Service Subscriber.